High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
<h4>Background</h4>Artemisinin derivatives are the key active ingredients in Artemisinin combination therapies (ACTs), the most effective therapies available for treatment of malaria. Because the raw material is extracted from plants with long growing seasons, artemisinin is often in sho...
Guardado en:
Autores principales: | Hiroko Tsuruta, Christopher J Paddon, Diana Eng, Jacob R Lenihan, Tizita Horning, Larry C Anthony, Rika Regentin, Jay D Keasling, Neil S Renninger, Jack D Newman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29329a6165654224a54f2846107a793c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nicotiana benthamiana as a production platform for artemisinin precursors.
por: Teun W J M van Herpen, et al.
Publicado: (2010) -
Acta Nº411
por: Banco Central de Chile
Publicado: (2019) -
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
por: Freek de Haan, et al.
Publicado: (2021) -
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
por: Jean-Paul Guthmann, et al.
Publicado: (2008) -
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
por: Paul M. O’Neill, et al.
Publicado: (2017)